Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

被引:17
|
作者
Ali, Monadil H. [1 ,2 ]
Alrasheedy, Alian A. [3 ]
Hassali, Mohamed Azmi [1 ]
Kibuule, Dan [4 ]
Godman, Brian [1 ,5 ,6 ,7 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden 11800, Malaysia
[2] Northern Border Univ, Coll Pharm, Dept Clin Pharm, Rafha 91911, Saudi Arabia
[3] Qassim Univ, Unaizah Coll Pharm, Qasim 51911, Saudi Arabia
[4] Univ Namibia, Fac Hlth Sci, Sch Pharm, 340 Mandume Ndemufayo Ave Pioneers Pk, Windhoek 13301, Namibia
[5] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, ZA-0204 Pretoria, South Africa
来源
ANTIBIOTICS-BASEL | 2019年 / 8卷 / 03期
关键词
MDR-TB; Predictors; Sudan; Tuberculosis; RISK-FACTORS; DRUG-RESISTANCE; PATTERN; STATE;
D O I
10.3390/antibiotics8030090
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB)
    Mokaddas, E. M.
    Ahmad, S.
    Eldeen, H. S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (06)
  • [22] A prioritised research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB)
    Gupta, R
    Espinal, M
    Beggs, A
    Laing, R
    Preger, J
    Castro, K
    Cegielski, JP
    De Luca, N
    Laserson, K
    Walton, W
    Wells, C
    Erokhin, V
    Mishin, V
    Vassilieva, I
    Karataev, ON
    Drobniewski, F
    Brander, L
    Katila, ML
    Malakhov, I
    Safonova, S
    Sheyanenko, O
    Starchenkova, N
    Farmer, P
    Hiatt, H
    Kim, J
    Mukherjee, J
    Murray, M
    Becerra, M
    Nardell, E
    Palmero, DJ
    Bonilla, C
    Solovic, I
    Mahmud, AM
    Rahman, A
    Melnyk, VM
    Portaels, F
    Creach, P
    Billo, N
    Repina, E
    Rakhishev, G
    Pechiorina, I
    Squire, SB
    Coker, R
    Arora, VK
    Sloutsky, A
    Timperi, R
    Henkens, M
    Lafontaine, D
    Slavuckij, A
    Vezhnina, N
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (05) : 410 - 414
  • [23] Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
    Sachin R Atre
    Megan B Murray
    Journal of Public Health Policy, 2016, 37 : 277 - 299
  • [24] Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
    Liu, Yongge
    Matsumoto, Makoto
    Ishida, Hidekaza
    Ohguro, Kinue
    Yoshitake, Masuhiro
    Gupta, Rajesh
    Geiter, Lawrence
    Hafkin, Jeffrey
    TUBERCULOSIS, 2018, 111 : 20 - 30
  • [25] Multidrug-resistant tuberculosis (MDR-TB) in a black African carceral area: Experience of Mali
    Toloba, Y.
    Ouattara, K.
    Soumare, D.
    Kanoute, T.
    Berthe, G.
    Baya, B.
    Konate, B.
    Keita, M.
    Diarra, B.
    Cisse, A.
    Camara, F. S.
    Diallo, S.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (01) : 22 - 27
  • [26] Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India
    Atre, Sachin R.
    Murray, Megan B.
    JOURNAL OF PUBLIC HEALTH POLICY, 2016, 37 (03) : 277 - 299
  • [27] The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)
    Palacios, E
    Guerra, D
    Llaro, K
    Chalco, K
    Sapag, R
    Furin, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (04) : 343 - 346
  • [28] Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia
    Mehari, Kibriti
    Asmelash, Tsehaye
    Hailekiros, Haftamu
    Wubayehu, Tewolde
    Godefay, Hagos
    Araya, Tadele
    Saravanan, Muthupandian
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2019, 2019
  • [29] Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Coker, R
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (08) : 649 - 650
  • [30] Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Gupta, R
    Raviglione, MC
    Espinal, MA
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (12) : 1078 - 1079